17:31 ET
Ulcerative Colitis Market Poised for Strong Expansion During the Forecast Period (2025-2034) Driven by Biologic and Novel Therapy Adoption Landscape | DelveInsight
The ulcerative colitis market is set for significant growth from 2025 to 2034, driven by rising disease prevalence, better diagnosis rates, and the adoption of advanced biologics and novel therapies. Key players like Abivax, Merck, Roche, and Eli Lilly are developing promising treatments. The US leads in market size and diagnosed cases. Despite advancements, a fully safe and curative option remains elusive, highlighting the need for new therapeutic strategies.
prnewswire·